These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 11096535)

  • 1. Vasodepressor Syncope.
    Kosinski DJ; Grubb B
    Curr Treat Options Cardiovasc Med; 2000 Aug; 2(4):309-316. PubMed ID: 11096535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma catecholamines and cyclic AMP response during head-up tilt test in patients with neurocardiogenic (vasodepressor) syncope.
    Abe H; Kobayashi H; Nakashima Y; Izumi F; Kuroiwa A
    Pacing Clin Electrophysiol; 1995 Jul; 18(7):1419-26. PubMed ID: 7567595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methods other than tilt testing for diagnosing neurocardiogenic (neurally mediated) syncope.
    Brignole M; Menozzi C
    Pacing Clin Electrophysiol; 1997 Mar; 20(3 Pt 2):795-800. PubMed ID: 9080512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Demonstration of syncope in patients after pacemaker implantation: role of head-up tilt test to distinguish neurocardiogenic vasodepressor syncope from pacemaker syndrome.
    Abe H; Kuroiwa A
    Pacing Clin Electrophysiol; 1996 Mar; 19(3):293-6. PubMed ID: 8657589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of alpha-adrenergic agonist therapy for prevention of pediatric neurocardiogenic syncope.
    Strieper MJ; Campbell RM
    J Am Coll Cardiol; 1993 Aug; 22(2):594-7. PubMed ID: 8101533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Value and limitations of noninvasive assessment of syncope.
    Hammill SC
    Cardiol Clin; 1997 May; 15(2):195-218. PubMed ID: 9164710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benefits of fludrocortisone in the treatment of symptomatic vasodepressor carotid sinus syndrome.
    da Costa D; McIntosh S; Kenny RA
    Br Heart J; 1993 Apr; 69(4):308-10. PubMed ID: 8489861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Driving safety among patients with neurocardiogenic (vasovagal) syncope.
    Bhatia A; Dhala A; Blanck Z; Deshpande S; Akhtar M; Sra AJ
    Pacing Clin Electrophysiol; 1999 Nov; 22(11):1576-80. PubMed ID: 10598959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vasodepressor syncope due to subclinical myocardial ischemia.
    Ascheim DD; Markowitz SM; Lai H; Engelstein ED; Stein KM; Lerman BB
    J Cardiovasc Electrophysiol; 1997 Feb; 8(2):215-21. PubMed ID: 9048251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurocardiogenic syncope in selected pediatric patients--natural history during long-term follow-up and effect of prophylactic pharmacological therapy.
    Biffi M; Boriani G; Bronzetti G; Frabetti L; Picchio FM; Branzi A
    Cardiovasc Drugs Ther; 2001 Mar; 15(2):161-7. PubMed ID: 11669410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can prodromal symptoms predict recurrence of vasovagal syncope?
    Fazelifar AF; Basiri HA; Tolooie A; Haghjoo M; Barakpour H; Emkanjoo Z; Abkenar HB; Zeighami M; Asgari F; Sadr-Ameli MA
    Cardiol J; 2008; 15(5):446-50. PubMed ID: 18810720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tilt training: a treatment for malignant and recurrent neurocardiogenic syncope.
    Reybrouck T; Heidbüchel H; Van de Werf F; Ector H
    Pacing Clin Electrophysiol; 2000 Apr; 23(4 Pt 1):493-8. PubMed ID: 10793440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The value of the clinical history in the differentiation of syncope due to ventricular tachycardia, atrioventricular block, and neurocardiogenic syncope.
    Calkins H; Shyr Y; Frumin H; Schork A; Morady F
    Am J Med; 1995 Apr; 98(4):365-73. PubMed ID: 7709949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical presentation and long-term follow-up of athletes with exercise-induced vasodepressor syncope.
    Calkins H; Seifert M; Morady F
    Am Heart J; 1995 Jun; 129(6):1159-64. PubMed ID: 7754948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of midodrine hydrochloride in neurocardiogenic syncope refractory to standard therapy.
    Sra J; Maglio C; Biehl M; Dhala A; Blanck Z; Deshpande S; Jazayeri MR; Akhtar M
    J Cardiovasc Electrophysiol; 1997 Jan; 8(1):42-6. PubMed ID: 9116967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of syncope.
    Hart GT
    Am Fam Physician; 1995 Jun; 51(8):1941-8, 1951-2. PubMed ID: 7762485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical characteristics of vasodepressor, cardioinhibitory, and mixed carotid sinus syndrome in the elderly.
    McIntosh SJ; Lawson J; Kenny RA
    Am J Med; 1993 Aug; 95(2):203-8. PubMed ID: 8356984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vasodepressor cough syncope masked by sleep apnea-induced asystole.
    Dickinson O; Nijjar PS; Detloff BL; Benditt DG
    J Cardiovasc Electrophysiol; 2012 Sep; 23(9):1024-7. PubMed ID: 22510089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurocardiogenic syncope: mechanisms, evaluation and treatment.
    Eltahawy EA; Grubb BP
    Future Cardiol; 2006 May; 2(3):325-34. PubMed ID: 19804090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Syncope in children and adolescents].
    Müller MJ; Paul T
    Herzschrittmacherther Elektrophysiol; 2018 Jun; 29(2):204-207. PubMed ID: 29761336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.